Form 8-K - Current report:
SEC Accession No. 0001193125-24-281696
Filing Date
2024-12-19
Accepted
2024-12-19 09:06:29
Documents
14
Period of Report
2024-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d149682d8k.htm   iXBRL 8-K 38703
2 EX-4.1 d149682dex41.htm EX-4.1 142814
  Complete submission text file 0001193125-24-281696.txt   349320

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA psnl-20241213.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE psnl-20241213_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE psnl-20241213_pre.xml EX-101.PRE 10819
16 EXTRACTED XBRL INSTANCE DOCUMENT d149682d8k_htm.xml XML 3496
Mailing Address 6600 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6600 DUMBARTON CIRCLE FREMONT CA 94555 650-752-1300
Personalis, Inc. (Filer) CIK: 0001527753 (see all company filings)

EIN.: 275411038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38943 | Film No.: 241561107
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)